Short communication: Defining optimality of a test for recent infection for HIV incidence surveillance

AIDS Research and Human Retroviruses

Volumn 30, Issue 1, 2014, Pages 45-49

  Kassanjee, Reshma ^a,b   McWalter, Thomas A ^a,c   Welte, Alex ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN G;

ARTICLE; CONSENSUS; DISEASE DURATION; DISEASE SURVEILLANCE; HEALTH SURVEY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INCIDENCE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; NATIONAL HEALTH ORGANIZATION; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURVIVAL; SUSCEPTIBLE POPULATION; TASK PERFORMANCE; WORLD HEALTH ORGANIZATION; ALGORITHM; EPIDEMIOLOGICAL MONITORING; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY;

ALGORITHMS; EPIDEMIOLOGICAL MONITORING; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; INCIDENCE;

EID: 84891815660     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2013.0113     Document Type: Article

References (30)

1. Le Vu S, Pillonel J, Semaille C, et al.: Principles and uses of HIV incidence estimation from recent infection testing - a review. Euro Surveill 2008;13(36):11-16.
2. Murphy G and Parry JV: Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill 2008;13(36):4-10.
3. Busch MP, Pilcher CD, Mastro TD, et al.: Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS 2010;24(18):2763-2771.
4. Welte A, McWalter TA, Laeyendecker O, and Hallett TB: Using tests for recent infection to estimate incidence: Problems and prospects for HIV. Euro Surveill 2010;15(24): pii = 19589.
5. Incidence Assay Critical Path Working Group: More and better information to tackle HIV epidemics: Towards improved HIV incidence assays. PLoS Med 2011;8(6):e1001045.
6. Hallett TB: Estimating the HIV incidence rate: Recent and future developments. Curr Opin HIV AIDS 2011;6(2):102-107.
7. Sharma UK, Schito M, Welte A, et al.: Workshop summary: Novel biomarkers for HIV incidence assay development. AIDS Res Hum Retroviruses 2012;28(6):532-539.
8. Parekh BS and McDougal JS: New approaches for detecting recent HIV-1 infection. AIDS Rev 2001;3:183-193.
9. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance: When and how to use assays for recent infection to estimate HIV incidence at a population level. 2011. www.who.int/diagnostics-laboratory/110906-guidance-hiv- incidence.pdf.
10. WHO Technical Working Group on HIV Incidence Assays: www.who.int/ diagnostics-laboratory/links/hiv-incidence-assay/en/. Accessed March 14, 2013.
11. The Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA): www.incidence-estimation .com/page/cephia. Accessed March 14, 2013.
12. Bill and Melinda Gates Foundation Letters of Inquiry (LOI): New Biomarkers for HIV Incidence Measurement. www .nuhs.edu.sg/wbn/slot/u3394/HIV- Incidence-LOI-Rules-and-Guidelines.pdf. Accessed March 14, 2013.
13. National Institutes of Health Funding Opportunity Announcements: HIV Incidence Assays with Improved Specificity. http://grants.nih.gov/grants/guide/ pa-files/PA-10-212.html. Accessed March 14, 2013.
14. Brookmeyer R and Quinn TC: Estimation of current human immunodeficiency virus incidence rates from a crosssectional survey using early diagnostic tests. Am J Epidemiol 1995;141(2):166-172.
15. Chaillon A, Le Vu S, Brunet S, et al.: Decreased specificity of an assay for recent infection in HIV-1-infected patients on highly active antiretroviral treatment: Implications for incidence estimates. Clin Vaccine Immunol 2012;19(8): 1248-1253.
16. Laeyendecker O, Brookmeyer R, Oliver AE, et al.: Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay. AIDS Res Hum Retroviruses 2012;28(8):816-822.
17. Wendel SK, Mullis CE, Eshleman SH, et al.: Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection. PloS One 2013;8(2):e55525.
18. McDougal JS, Parekh BS, Peterson ML, et al.: Comparison of HIV type 1 incidence observed during longitudinal followup with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retroviruses 2006;22(10):945-952.
19. Hargrove JW, Humphrey JH, Mutasa K, et al.: Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS 2008;22(4):511-518.
20. McWalter TA and Welte A: Relating recent infection prevalence to incidence with a sub-population of assay nonprogressors. J Math Biol 2010; 60(5):687-710.
21. Kassanjee R, McWalter TA, Barnighausen T, and Welte A: A new general biomarker-based incidence estimator. Epidemiology 2012;23(5):721-728.
22. Efron B and Tibshirani RJ: An Introduction to the Bootstrap (Monographs on Statistics and Applied Probability 57). Chapman & Hall/CRC, Boca Raton, FL, 1993.
23. Brookmeyer R: On the statistical accuracy of biomarker assays for HIV incidence. JAIDS 2010;54(4):406-414.
24. Parekh BS, Kennedy MS, Dobbs T, et al.: Quantitative detection of increasing HIV type 1 antibodies after seroconversion: A simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002;18(4):295-307.
25. Karita E, Price M, Hunter E, et al.: Investigating the utility of the HIV-1 BED capture enzyme immunoassay using crosssectional and longitudinal seroconverter specimens from Africa. AIDS 2007;21(4):403-408.
26. Sakarovitch C, Rouet F, Murphy G, et al.: Do tests devised to detect recent HIV-1 infection provide reliable estimates of incidence in Africa? JAIDS 2007;45(1):115-122.
27. Guy R, Gold J, Calleja JM, et al.: Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: A systematic review. Lancet Infect Dis 2009;9(12):747-759.
28. Masciotra S, Dobbs T, Candal D, et al.: Antibody aviditybased assay for identifying recent HIV-1 infections based on Genetic SystemsTM 1/2 Plus O EIA. Abstract 937 at the 17th Conference on Retroviruses and Opportunistic Infection, 2010.
29. Braunstein S, Nash D, Ingabire C, Mwamarangwe L, and Wijgert Jvd: Performance of BED-CEIA and Avidity Index assays in a sample of ART-näve, female sex workers in Kigali, Rwanda. Abstract 939 at the 17th Conference on Retroviruses and Opportunistic Infection, 2010.
30. Park SY, Love TM, Nelson J, Thurston SW, Perelson AS, and Lee HY: Designing a genome-based HIV incidence assay with high sensitivity and specificity. AIDS 2011;25(16):F13-F19.